Research Use Only, commonly abbreviated RUO, describes the intended context in which Grey Axis Research materials are offered. Grey Axis Research products are intended for in-vitro laboratory research and analytical purposes only. Human or animal use, including clinical, medical, diagnostic, therapeutic, or cosmetic applications, is strictly prohibited.
Read RUO language together with the product information, batch documentation, website terms, and applicable laboratory requirements. The research-use statement establishes Grey Axis’s intended-use boundary; it does not replace a researcher’s responsibility to evaluate the material, the available documentation, and the requirements that apply to a specific project.
What the RUO Statement Communicates
Research-use labeling communicates the supplier’s stated intended use and distribution position for the material. It separates laboratory research from clinical, diagnostic, therapeutic, and consumer applications.
In FDA guidance on RUO in vitro diagnostic products, the agency emphasizes that research-use labeling must match the manufacturer’s actual intended use and distribution practices. That guidance is specific to IVD products, but it illustrates an important general principle: a research-use statement should remain consistent with the claims, descriptions, and support provided for the product.
For Grey Axis materials, product pages and supporting content should remain focused on material identification, available analytical documentation, and laboratory recordkeeping. They should not provide clinical interpretation or suggest that a material is suitable for diagnosing, preventing, or treating a condition.
What RUO Does Not Establish
The words Research Use Only do not by themselves establish the chemical identity, purity, quantity, sterility, stability, or fitness of a material for a particular experiment. An RUO statement does not answer those questions; they require review of the applicable documentation and, when necessary, additional testing by the purchasing laboratory.
An RUO statement also should not be interpreted as proof that a government agency has approved, cleared, or evaluated a product. It is an intended-use limitation, not a substitute for analytical evidence or legal review.
Researchers should avoid treating an RUO label as confirmation of:
• Identity or purity beyond the tests documented for the applicable sample or batch
• Sterility when a validated sterility analysis is not reported
• Suitability for human or animal use
• Therapeutic effectiveness or clinical performance
• Compliance with every law, protocol, or institutional requirement that may apply to a project
How Analytical Documentation Supports Research Review
Analytical documentation can provide evidence about the submitted sample and the tests listed in a report. Depending on the material and laboratory, documentation may include information about identity, chromatographic purity, material amount, microbial counts, or other measured characteristics.
The full available report should be reviewed rather than relying on a single percentage, a pass designation, or a general product-page statement. The product name, batch or lot number, testing party, method, result, and any stated specification all help define what the document does and does not support.
Researcher Responsibilities
The purchasing laboratory should determine whether a material and its available documentation are appropriate for the planned research and its institutional requirements. Depending on the project and jurisdiction, researchers may also need to consider applicable institutional procedures, safety requirements, and other legal or regulatory requirements.
Before incorporating a material into a research workflow, researchers should consider:
• Whether the product and batch information match the material received
• Which analytical tests were actually performed
• Whether the documented results answer the question relevant to the experiment
• Whether additional qualification or testing is required
• Whether storage, handling, recordkeeping, and disposal procedures have been established
• Whether the planned work is consistent with Grey Axis’s stated research-only use restrictions
Maintaining Consistent Research-Only Records
Research records should preserve the connection between the material, its batch or lot number, the applicable analytical report, and the experimental work in which it was evaluated. Maintaining that connection can help prevent documentation from one batch from being applied to another and can support later review of the research record.
If the applicable documentation cannot be located, the report does not clearly identify the submitted sample, or the intended work falls outside Grey Axis’s stated research-only use restrictions, the material should not be treated as qualified on the basis of the RUO label alone.
View the Grey Axis COA Library
Research Use Only
Grey Axis Research products are intended for in-vitro laboratory research and analytical purposes only. Human or animal use, including clinical, medical, diagnostic, therapeutic, or cosmetic applications, is strictly prohibited.